2 active not recruiting, 2 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 2, Recruiting 2 |
Follow Erwinase: new trials by email Literature Review of Erwinase trials Research Report on Erwinase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations Allogeneic Hematopoietic Stem Cell Transplantation, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Acute Myeloid Leukemia | Phase 3 | Recruiting | Children's Oncology Group | 1400 | 2020-07-21 | 2026-09-17 |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 6720 | 2019-07-03 | 2026-11-12 |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 Blinatumomab, Bortezomib, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric | Phase 3 | Recruiting | Martin Schrappe | 5000 | 2018-07-15 | 2025-04-06 |
| Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome Asparaginase, Asparaginase Erwinia chrysanthemi, Cytarabine - Acute Myeloid Leukemia, Down Syndrome | Phase 3 | Active not recruiting | Children's Oncology Group | 280 | 2015-12-23 | 2026-08-19 |
Down Syndrome (2) · Leukemia, Myeloid, Acute (2) · Burkitt Lymphoma (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Children's Oncology Group (2) · Martin Schrappe (1) · National Cancer Institute (NCI) (1)
Australia (4) · Canada (3) · Puerto Rico (3) · United States (3) · New Zealand (2) · Austria (1) · Czechia (1) · Germany (1) · Israel (1) · Italy (1) · Saudi Arabia (1) · Slovakia (1) · Switzerland (1)
Jason N Berman (1) · Martin Schrappe, MD (1) · Sumit Gupta (1) · Todd M Cooper (1)
PMID 33843815, PMID 33844429, PMID 35129146, PMID 38107263, PMID 38841802, PMID 38947228, PMID 39651791, PMID 41124669, PMID 41671463, PMID 42497367, PMID 42748428
U10CA180886 (3)